Calliditas Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.638; its P/E ratio is -11.03; Calliditas Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	-	kr 260.06M	kr 64.05M	kr 49.73M	kr 31.18M
Gross Profit	-	kr 255.73M	kr 61.66M	kr 49.12M	-
EBIT	-	kr -36.23M	kr -209.84M	kr -208.37M	kr -222.13M
EBITDA	-	kr -36.23M	kr -209.84M	kr -208.37M	kr -222.13M
Net Income Common Stockholders	-	kr -9.11M	kr -192.43M	kr -207.05M	kr -219.17M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	kr 1.25B	kr 736.16M	kr 846.80M	kr 825.41M	kr 955.51M
Total Assets	kr 1.95B	kr 1.52B	kr 1.46B	kr 1.34B	kr 1.46B
Total Debt	kr 728.82M	kr 467.32M	kr 458.03M	kr 214.49M	kr 213.22M
Net Debt	kr -520.27M	kr -268.84M	kr -388.77M	kr -610.92M	kr -742.29M
Total Liabilities	kr 1.20B	kr 792.17M	kr 737.20M	kr 473.20M	kr 451.63M
Stockholders Equity	kr 766.26M	kr 725.94M	kr 721.09M	kr 871.14M	kr 1.01B
Cash Flow	-
Free Cash Flow	-	kr -124.72M	kr -225.23M	kr -191.42M	kr -161.25M
Operating Cash Flow	-	kr -124.72M	kr -225.23M	kr -191.42M	kr -161.25M
Investing Cash Flow	-	kr -888.00K	kr -139.00K	kr -2.65M	kr -5.34M
Financing Cash Flow	-	kr -2.57M	kr 235.87M	kr 60.05M	kr -41.29M

Currency in SEK

Calliditas Therapeutics Earnings and Revenue History

Income Statement >

Calliditas Therapeutics Debt to Assets

Balance Sheet >

Calliditas Therapeutics Cash Flow

Cash Flow >

Calliditas Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing